Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

Inclusion Criteria: * Premenopausal female patient with a clinical diagnosed vulvo-vaginal candidiasis * Regularly menstruating women with normal gynaecological status * Patient must use a contraception method * Having given a written informed consent prior to selection * Covered by Health Insurance System and / or in compliance with the recommendations of National Law in force relating to biomedical research. Exclusion Criteria: * Pregnancy or breast feeding. * Tumors in the genital tract or beast. * Hypersensitivity to the study product. * Uterine or vaginal bleeding of unknown origin. * Use of systemic or intravaginal antibiotic or antifungal agents in the previous 14 days. * Concomitant medication with antimycotics for other diagnoses. * Woman with known transmitted infections such as Neisseria gonorrhoea, Chlamydia trachomatis, Treponema pallidum, herpes simplex, Trichomonas vaginalis, human papilloma virus, HIV 1 or 2. * Immunocompromised individuals. * Subjects not willing to stop taking probiotics in the form of dietary supplements or convenient goods * Subject who, in the judgment of the Investigator, is likely to be non-compliant or uncooperative during the study, or unable to cooperate because of a language problem, poor mental development. * Subject under administrative or legal supervision. * Subject who participate to a previous study within 3 months.